eTour: MD Anderson Cancer Research, Clinical Trials & Survivorship
This video is part of the MD Anderson eTour, a visual snapshot of MD Anderson’s campus, services and people. To take the eTour, visit www.mdanderson.org
Video Rating: 0 / 5
The NCI Clinical Trials Search Form (www.cancer.gov allows you to search a list of more than 8000 clinical trials now accepting participants, as well as a longer list of trials no longer recruiting. This video is Part Two: How to narrow your search, read your search results, and take next steps. For additional guidance, see “Help Using the NCI Clinical Trials Search Form” (www.cancer.gov
JVZoo Product Feed
GRACEcast-100_Lung-Cancer_MM in LC Pt 5: Dr. Spigel on Incorporating Targets into Clinical Trials
cancerGRACE.org Dr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include patient subgroups based on molecular markers.
JVZoo Product Feed
Categories: Videos Tags: spigel, incorporating, targets, gracecast100_lungcancer_mm, into, clinical, trials
Dr. West Talks About Anticipated Future Clinical Trials
H. Jack West, MD, medical director of the Thoracic Oncology Program at the Swedish Cancer Institute in Seattle, Washington, explains his anticipation to see an overall survival benefit emerge from the PARAMOUNT study examining continuation maintenance with pemetrexed in non-small cell lung cancer. He mentions a strong interest in clinical trials examining next generation studies such as crizotinib in patients that do not have the ALK rearrangement and BRAF targeted therapies which are still in their infancy.
Video Rating: 0 / 5
JVZoo Product Feed
GRACEcast-025_Lung-Cancer_Questions and Trials for NSCLC
cancergrace.org This slide presentation by Dr. Heather Wakelee, medical oncologist at Stanford University, describes the key clinical research issues being addressed in post-operative treatment of resected non-small cell lung cancer (NSCLC).
Video Rating: 0 / 5
JVZoo Product Feed
Categories: Videos Tags: nsclc, gracecast025_lungcancer_questions, trials
Emphysema Clinical Trials – Franklin Square Hospital Center
Clinical trials are leading to new treatments and interventions… Visit: www.franklinsquare.org
Video Rating: 0 / 5
Christopher Drake explains how Buteyko’s Method reverses the symptoms of emphysema and COPD
Video Rating: 5 / 5
JVZoo Product Feed
Participating In Cancer Clinical Trials: Part 1 – What You Need To Know
Part 1 of a National Cancer Institute cancer clinical trials educational video created for people who are considering participation in a trial. The video explains and answers common questions about the types of clinical trials, how they are conducted, and factors to think about when deciding whether or not to participate in a trial. The video also features actual patients who share their reasons and decisions about participating in cancer clinical trials. View Part 2 of this video: www.youtube.com To order the entire Understanding Cancer Clinical Trials DVD and other free clinical trial educational materials, call NCI’s Cancer Information Service at 1-800-4-CANCER (1-800-422-6237) or visit www.cancer.gov . You can find additional information about clinical trials online at www.cancer.gov NCI’s Cancer Information Service is also available to answer other questions you may have: 1-800-422-6237 For Copyright Notice and Restrictions please visit our Web site at www.cancer.gov
Video Rating: 5 / 5
JVZoo Product Feed
Are there any clinical trials being done that could type and screen cancer samples to specific chemotherapies?
Question by Dks97: Are there any clinical trials being done that could type and screen cancer samples to specific chemotherapies?
Sort of like how blood is typed and screened. If a patient knew how their cells reacted to a specific regimen, it would save time going down a long list of chemotherapies. If a sample is taken and tested before chemo is scheduled to start, a patient could go right to that specific drug match and benefit. My mother has breast cancer and is on her 3rd drug combo. We keep going down a list of compatible drugs for her cancer type not knowing which will be a good long term match for her.
Best answer:
Answer by bmac
Here is the clinical trials site.
http://www.clinicaltrials.gov/
What do you think? Answer below!
JVZoo Product Feed
Categories: News Tags: specific, chemotherapies, samples, done, could, there, trials, being, clinical, screen
Advocacy in Action: Role of Global Advocate Community in Research & Clinical Trials
This discussion is led by Prof. David Kerr (President of ESMO), Diane Blum (CEO Lymphoma Research Foundation) Regina Vidaver (Exec. Dir. of the Nat’l Lung Cancer Partnership) and Selma Schimmel (Founder & CEO Vital Options International. Featuring Cancer Advocates: Arin Assero (International Myeloma Foundation), Andrea Evans (Y-Me National Breast Cancer Foundation) and Kim Ryan (Fight Colorectal Cancer).
Video Rating: 0 / 5
JVZoo Product Feed
Categories: Videos Tags: research, advocacy, clinical, community, role, advocate, global, action, trials
Why are clinical trials important for early detection research?
Simone Marticke, PhD, Canary Foundation Scientific Program Manager, explains the purpose of clinical trials and how they impact early cancer detection research. To learn more about the Canary Center at Stanford, visit: www.canaryfoundation.org/canary-center
Video Rating: 0 / 5
JVZoo Product Feed
Dr. Reckamp on Current Heat Shock Protein Clinical Trials
Karen Reckamp, MD, MS, assistant professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, California, describes the various clinical studies currently underway examining the use of heat shock proteins. Clinical trials are currently looking specifically at ALK translocated, crizotinib resistance, and patient that have not yet received crizotinib. Further examination is being completed into heat shock proteins in combination with docetaxel and other targets and biomarkers that specify which patients will have the most benefit.
Video Rating: 0 / 5
JVZoo Product Feed
Management of IPF: Recent Advances in Prognosis, Co-Morbidities and Clinical Trials Part 1 of 10
Presentation by Imre Noth, MD, Associate Professor of Medicine at the University of Chicago for the 2009 Pulmonary Fibrosis Symposium at St. Mary’s Medical Center in Evansville, Indiana. Part 1 of 10.
Video Rating: 0 / 5
Savannah Aulger will never have snapshots with her father on her first birthday, on Christmas or at a school event. The only picture she will ever have of them is the one as sweet as it is heartbreaking. Hooked up to an oxygen mask at the hospital, the man she would call dad cradled her in his arms for 45 minutes. He sobbed. He smiled. And there was no doubt that he loved her. “He would talk to my stomach when I was pregnant,” Diane Aulger said of her husband. “He was so excited for her.” The next day, Mark Aulger slipped into a coma. The Aulger family of The Colony, Texas, had a lot to rejoice about in the weeks before Savannah’s Jan. 18 birth, which was induced two weeks early so her father could hold her. A home movie on Christmas showed a pregnant Diane Aulger, 31, handing out gifts to their four children, the oldest of whom is 15. Mark, 52, who had just received the news that he had beaten cancer, played the guitar, providing a soundtrack for the Christmas morning festivities. On Jan. 3, life threw a curveball. ABC News Diane Aulger induced labor so her dying… View Full Size Homeless Man’s Dying Wish: Dog Reunion Watch Video Dying Man Gets Wish for Citizenship Watch Video Dying Boy Meets Santa Watch Video Mark Aulger was admitted to the hospital, unable to breathe. Doctors told him that eight months of chemotherapy had ravaged his lungs and diagnosed him with pulmonary fibrosis. “We thought he could get on steroid treatment and oxygen and live for years,” Diane …
JVZoo Product Feed
Categories: Videos Tags: clinical, prognosis, management, recent, comorbidities, part, advances, trials
Clinical Trials of the New York Doctors
Clinical Trials of the New York Doctors
Article by David H. Urmann
Some of the New York doctors are involved in research studies for the development of more effective treatment methods of various diseases. These doctors work hand in hand with other institutions and research facilities to attain their objective of a better lifesaving health care for all the residents of New York.
Doctors understand the feeling of patients and their family when they need to enter hospitals for medical attention. Most often, they are afraid the impending results of laboratory tests and other treatments.
In this respect, medical doctors make it a point to conduct consultations with their patients and explain possible medical proceedings that patients will have to undergo. As much as possible, they make their patients more comfortable with the medical proceedings.
In line with providing better medical services, the New York doctors members and residents of New York Presbyterian Hospital, conducts research studies on medicines particularly for the clinical phase. The research will greatly help doctors of the New York- Presbyterian Hospital to provide patients relatively more choices of lifesaving support and well-developed applications on health care service.
Dedicated doctors from Columbia University College of Physicians & Surgeons and Weill Medical College of Cornell University are collaborating to come up with positive results for this objective. As part of the collaboration, clinical trials have been established in order to provide patients the best means to access medical and therapeutic treatments easily.
These patients who take part of the trials undergo strict guidelines and careful supervision in order to ensure a safe and beneficial procedure.The Columbia University College of Physicians & Surgeons has so many research centers where various research studies on specific subjects including molecular therapeutics, neurobiology, reproductive, women’s health, cancer genetics, and Alzheimer’s disease are conducted. The Columbia’s Irving Center for Clinical Research is one of the institutions equipped with the most modern facilities and provides clinical investigators enough equipment to conduct studies for the benefit of contemporary medicine.
On the other hand, Weill Medical College of Cornell University doctors deals with clinical research on areas of genetics and gene therapy, neuroscience, structural biology, AIDS, cancer, and psychiatry.Some of the New York doctors are:Dr. Robert J. Kaner, M.D.Address: 520 E 70th Street, Ste 505, New York, NY 10021Phone: (212) 746-2250Fax: (212) 746-8808
Dr. Kaner is a specialist in Pulmonary Disease Medicine, Critical Care Medicine and Board Certified in Internal Medicine.
Areas of expertise include:* Lung Cancer* Asthma* Lung Disease* Chronic Obstructive Pulmonary Disease (COPD)* Interstitial Lung Disease
Education and Training:* Earned his Doctors Degree at the University of Pennsylvania School of Medicine.* Internship – Hospital of University of Pennsylvania* Residency – Hospital of University of Pennsylvania* Fellowship – Hospital of University of Pennsylvania
Dr. David R. Bickers, M.D.Address: 16 East 60th Street, Suite 300, New York, NY 10022Phone: (212) 326-8465Fax: (212) 326-8567
Address: 161 Ft. Washington Avenue, 12 Floor, New York, NY 10032Phone: (212) 305-5293Fax: (212) 795-1859
Areas of Expertise:* Skin Cancer* Psoriasis* Baldness* Phototherapy* Mole and Wart Removal
Education and Training:* Medical School – University of Virginia School of Medicine* Internship – University of Iowa College of Medicine* Residency – New York University Medical Center* Fellowship – New York University Medical Center
Dr. Robert R. Walther, M.D.Address: 16 East 60th Street, Suite 300, New York, NY 10022Phone: (212) 326-8465Fax: (212) 326-8567
Dr. Walther is a Board Certified Dermatologist with expertise in:* Skin Cancer* Psoriasis* Dermatologic Surgery* Mole and Wart Removal
Education and Training:* Medical School – North Carolina Memorial Hospital* Medical School – University of North Carolina* Internship – University of Miami Hospital* Residency – Columbia Presbyterian Medical Center, New York* Residency – University of Miami Hospital
About the Author
For more information on New York Doctors and Doctors List please visit our website.
Related Lung Cancer Clinical Trials Articles
JVZoo Product Feed
Revitalizing the Cancer Clinical Trials System: The Community Perspective
Stephen Grubbs, MD, Investigator, Christiana Care Community Oncology Program and a community oncologist talks about the importance of offering clinical trials as a treatment option for cancer patients in community oncology setting. He also discusses the critical role of the government sector in supporting clinical trials that may not be appropriate or of interest to the pharmaceutical or biotechnology sectors. He also talks about how changes in our understanding the biology of cancer will affect the types of trials that will need to be developed. Information on The Nation’s Investment in Cancer Research: www.cancer.gov
Video Rating: 0 / 5
Created at the Center for Health Enhancement Systems Studies at the University of Wisconsin, this CHESS program is aimed mainly at improving the lives of caregivers as they helped a family member with lung cancer.
JVZoo Product Feed
Categories: Videos Tags: revitalizing, community, system, clinical, perspective, cancer, trials
Dr. Li Discusses the PROFILE Crizotinib Clinical Trials
Tianhong (Tina) Li, MD, PhD, assistant professor, co-director of Phase I Program, UC Davis Cancer Center, discusses the PROFILE clinical trials examining ALK-positive non-small cell lung cancer patients that led to the FDA approval of Pfrizer’s crizotinib (Xalkori). The 1001 trial examined 119 ALK-positive NSCLC patients with a 61% overall response rate and 69% partial response rates. The 1005 trial also exhibited great results, with 136 patients and a 50% overall response rate, including 1 complete response and 67% partial response.
JVZoo Product Feed
Cantonese Part 18 – Clinical Trials – Living with Lung Cancer
Video Rating: 0 / 5
JVZoo Product Feed
Clinical Trials
Mesothelioma Clinical Trials www.mesorc.com Mesothelioma clinical trials are medical research studies used to test new mesothelioma treatments to see how they affect people. Some mesothelioma patients participate in clinical trials as part of their treatment. Before deciding whether to participate in a mesothelioma clinical trial, you may want to find out what is involved in the trial and discuss the option with your doctors and family members. Some questions you might want to ask your doctor about clinical trials include: • What treatments will be used? • How are these treatments different from standard treatments? • What are the possible side effects from these treatments? • Where will I receive treatments? • How much will the treatments cost me? Getting answers to these questions may help you decide whether a mesothelioma clinical trial is right for you and help ease your fears. Remember that participating is your choice. Your doctor will never enroll you in a clinical trial without your written permission. Treatments used in mesothelioma clinical trials may have real benefits, but the study may find that the treatments used are not better than standard mesothelioma treatments. The information doctors learn from clinical trials contributes to the knowledge of and progress against cancer. For more information on Mesothelioma Clinical Trials, please visit the following pages: Clinical Trial FAQs Phases of Clinical Trials Current Clinical Trials
Video Rating: 0 / 5
JVZoo Product Feed
More Than Thirty Mesothelioma Clinical Trials Are Underway
More Than Thirty Mesothelioma Clinical Trials Are Underway
Article by Agatha Simona
Clinical trials are human studies of new drugs and treatments to determine whether or not they should be approved by the FDA. Clinical trials for mesothelioma are ongoing, primarily at major medical centers around the country. Because mesothelioma is an aggressive cancer, many trials are focused on ways to detect it earlier and treat it more effectively with various combinations of therapies.
Although participation in a mesothelioma trial may sound like a good way to connect with promising new treatments, not every mesothelioma patient is a candidate. Because clinical trials are established with specific goals, most have very specific guidelines as to the type of patients they are willing to treat. For example, some trials only accept patients who have received little or no benefit from other therapies, while others only take people who have not yet started any treatment.
Mesothelioma trials like all clinical trials are conducted in three phases. Phase I trials generally recruit a smaller number of participants and focus on determining safety and dosing. In Phase II trials, researchers try to determine if a drug or treatment actually has efficacy. If the treatment shows promise and is safe, its effectiveness is compared to that of existing treatments in a Phase III trial.
There are both advantages and disadvantages to being involved in a mesothelioma clinical trial. Even if a patient meets the criteria for a trial and is accepted to participate, there is no guarantee that they will receive the new treatment, since some trials require a group of participants to receive the old treatments for a basis of comparison. In addition, the time spent ‘experimenting’ in a clinical trial could be used instead to be receiving a proven existing treatment.
On the positive side, clinical trial participants often receive excellent health care since they must be monitored closely as part of the study. There is the possibility that a new treatment may offer real benefits over existing treatments. And there is the intangible benefit of at least increasing a knowledge base that may lead to better treatments in the future.
Although chemotherapy, radiation and surgery remain the primary treatments again mesothelioma, many of the newest trials are focused on therapies that are able to target the tumor cells more effectively, without harming surrounding tissues. Some of these newer drugs aim to slow tumor growth by robbing cells of vital enzymes, inhibiting their ability to replicate, or harnessing the body’s own immune system to attack them.
The National Institute of Health provides a current list of ongoing clinical trials for mesothelioma. Some of the studies going on now include:
• Studies of several new oral medications against advanced pleural mesothelioma where traditional chemotherapy has failed
• A study of an under-the-tongue spray medication for mesothelioma pain
• Several studies on the addition of a third chemotherapy drug to the standard two-drug mixture
• A study on the effectiveness of video-assisted surgery for mesothelioma tumors
• A study on the effectiveness of administering a heated chemotherapy drug in the operating room, immediately following mesothelioma surgery
• A study on a new drug, AZD2171, that may stop the growth of tumors in patients who are not candidates for surgery
• A study on the effectiveness of combining chemotherapy with Intensity Modulated Radiation Therapy in mesothelioma
• Gene therapy for pleural mesothelioma
More than 30 clinical trials for mesothelioma are currently underway in the U.S. For a complete list of studies that are recruiting, locations and participation requirements, visit the National Cancer Institute.
About the Author
Mesothelioma cancer patient resource with questions and answers about mesothelioma, a deadly cancer caused by asbestos exposure.
More Mesothelioma Surgery Articles
JVZoo Product Feed
Dr. Kris on the Crizotinib Clinical Trials
Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York on the Crizotinib Clinical Trials
JVZoo Product Feed
Categories: Videos Tags: kris, crizotinib, clinical, trials
Clinical trials for an operation for sufferers of lung cance
Clinical trials for an operation for sufferers of lung cancer caused by asbestos dust are starting at a Leicester hospital.
JVZoo Product Feed
